Tuesday, November 17, 2026

Willbase and Alfresa Healthcare form capital and business alliance!

Willbase formed a capital and business alliance with Alfresa Healthcare, a subsidiary of Alfresa Holdings and a self-medication wholesaler!

Background and Objectives

Willbase was established in 2016 to support sales promotion and marketing in the healthcare domain. With the vision of "making healthcare normal and natural," Willbase is working to solve issues in the healthcare industry with its DX tools and consulting capabilities that utilize the latest technology. For the purpose of promoting self-medication, we have developed the "CureBell*1" website to help consumers choose the right OTC drugs and supplements, while for OTC retailers such as drugstores, we have developed the "D We provide "D-Counselor neo*2", a customer service support application that strongly supports both appropriate sales and sales promotion, to drugstores and other OTC retailers, and have a wealth of data accumulated through these DX tools on healthcare product sales and pre-purchase behavior of consumers.

The Alfresa Group, with its parent company, Alfresa Holdings Corporation, as a pure holding company, is Japan's No. 1 ethical pharmaceutical wholesaler with consolidated sales of more than 2.8 trillion yen, and is engaged in businesses ranging from the development and manufacture of pharmaceutical products to distribution and operation of dispensing pharmacies.
We have formulated the "Alfresa Group Medium- to Long-Term Vision," a medium- to long-term business strategy and financial and capital strategy through fiscal 2032, aiming to create social value in the form of "extension of healthy life expectancy," "contribution to community medicine," and "healthcare innovation" through strengthening and expanding total supply chain services. 3.

Alfresa Healthcare promotes "self-medication" and "self-prevention" to contribute to the realization of a healthy and vibrant society, and provides products and services related to "beauty and health" such as health foods, lifestyle-related products, and beauty care products, mainly over-the-counter drugs, to drugstores, pharmacies, drug stores and other retail outlets. We also provide products and services related to "beauty and health" to drugstores, pharmacies, drugstores, and other retail outlets. In addition, we have developed our own service, "Alfresa Healthcare Solution (AHS)," and are promoting sales floor proposals through exhibitions such as "Life Support Fair" and "Solution Proposal Business Meetings," as well as data-based initiatives such as shelf allocation proposals based on the Consumer Purchase Decision Tree (CDT)*4 . We also provide comprehensive support to resolve issues faced by our customers and business partners by promoting "Life Support Fair," "Solution Proposal Business Meetings," and other exhibitions.

With the conclusion of this agreement, we will work together with Alfresa Healthcare to strongly promote the spread and expansion of the DX tools that we provide. We will also utilize our wealth of data to develop new sales and purchase methods for healthcare products, market forecasts for healthcare products, new product planning, and sales promotion and other support services. Through these activities, we will realize our vision of "making healthcare normal and natural" and contribute to solving healthcare-related issues in Japanese society.

1 CureBell: A website that supports the appropriate selection of over-the-counter drugs and supplements for the purpose of promoting self-medication. In October 2024, a supplement selection function was added, enabling comparison of prices, nutritional ingredients, and GMP/doping certification in a unified format, making it a highly reliable platform used not only by the general public but also by healthcare professionals. It has become a highly reliable platform used not only by the general public but also by medical professionals.
https://curebell.jp
2 D-Counselor neo: An application specialized in supporting customer service for OTC drug sales. It has a function that enables pharmacists and registered sales representatives to select appropriate products based on a thorough interview of symptoms, medical history, and preferences. It also has a function to check customer information and inventory status at each store in real time, and an alert function that contributes to the prevention of drug abuse among young people, thus achieving both sales promotion and appropriate sales.
3 Reference: May 15, 2023 announcement, "Alfresa Group Medium- to Long-term VisionThe Formulation of the "The New York Times."
4 Consumer Purchase Decision Tree (CDT): An analytical tool that visualizes the decision-making process in a hierarchical manner when consumers select products.

Details of Business Alliance

(1) Alfresa Healthcare's use and sale of various data held by the Company
(2) Sales of services provided by Alfresa Healthcare
(3) Collaboration in areas agreed upon by the Company and Alfresa Healthcare
The details of the work will be discussed and a separate contract will be signed in the future.

Alfresa Healthcare Corporation|Company Profile (as of April 28, 2025)

name of companyAlfresa Healthcare Corporation
(Alfresa Healthcare Corporation)
EstablishmentOctober 1, 2011
LocationNihonbashi Hakozaki-Bldg. 6 & 7F, 24-1 Nihonbashi Hakozaki-cho, Chuo-ku, Tokyo
representativeMakoto Nishida, President and Representative Director
Representative Director Hisashi Katsuki
capital stock499 million yen
Net sales (FY2023 actual)262.8 billion yen (FY3/2024)
Number of Employees402 (as of March 31, 2024)
BusinessWholesale of over-the-counter (OTC) pharmaceuticals, quasi-drugs, dairy products for child care, sundries, etc.

schedule

Date of conclusion of capital and business alliance agreement: March 24, 2025

Willbase, Inc.

name of companyWillbase, Inc.
EstablishmentDecember 2016
Location5F H1O Nihonbashi Kobunacho, 8-6 Nihonbashi Kobunacho, Chuo-ku, Tokyo
representativeYuki Tanaka
uniform resouce locatorhttps://www.willbase.co.jp/

PORT Editorial Officehttps://port.creww.me/
PORT by Creww is an open innovation media for startups, entrepreneurs, entrepreneurs in recovery, and companies seeking to create new businesses on the theme of social issues, operated by Creww Co.
- Advertisment -
- Advertisment -

Featured

東芝のオープンイノベーション、協業検討に進む2社が決定 ダイナミックマッププラットフォームとArithmerを選定

ReGACY Innovation Group株式会社(東京都千代田区)は、企画・運営パートナーとして支援する株式会社東芝の「Toshiba OPEN INNOVATION PROGRAM 2026」で、協業検討に進む参加企業2社が決定したと発表した。7月に募集した共創プランの中から、ダイナミックマッププラットフォーム株式会社とArithmer株式会社を選定。両社は東芝グループの「Hybrid-3D LiDAR」と「気象データサービス」を活用し、物流・インフラ分野などでの新たなソリューション共創を目指す。12月中旬の成果発表会に向け、実証と事業性検証を進める。 本プログラムでは、2026年7月6日から7月26日まで参加企業を募集しており、応募のあった共創プランの中から、ダイナミックマッププラットフォーム株式会社、Arithmer株式会社の2社が選定されました。 両社は、東芝グループが保有する「Hybrid-3D LiDAR」および「気象データサービス」の技術・データを用いて、物流・インフラ分野やデータ活用領域における新たなビジネスソリューションの共創を目指します。 今後は、12月中旬に予定されている成果発表会に向けて実証や事業性検証を進めるとともに、事業化を見据えた協業の検討を加速していきます。

新潟日報社、オープンイノベーションプログラム2026ピッチ審査会で「三ツ目」「想ひ人」2社を選定

新潟日報社は8月4日、「新潟日報社 オープンイノベーションプログラム2026 ピッチ審査会」を開催した。Creww株式会社が提供する「Creww Growth」を活用し、5月15日から6月15日にかけて新潟県や社会が抱える課題解決に向けた協業アイデアを募集。応募61件の中から書類審査を通過した8社がピッチに参加し、審査の結果「三ツ目」(新潟県三条市)と「想ひ人」(東京都)の2社を選定した。今後は実証事業等を通じて事業化を進める予定。

【ヤマサキ × BeeInventor】高温下での過酷な作業環境から、データは命を守れるか——創業151年の工業炉建設会社とスマートヘルメット新興企業が挑む「熱中症ゼロ」の現場

明治8年創業の株式会社ヤマサキは、建設業界向けアクセラレータープログラム「ヤマサキ×オープンイノベーションプログラム2024」を通じて、スマートヘルメットを手がけるビーインベンターとのPoCを実施した。内部温度800度を超える製鉄炉の傍らで働く現場作業員の熱中症リスクをAIで早期検知するという挑戦は、今まさに第2フェーズへと移行しようとしている。プロジェクトリーダーの向井裕一氏と、BeeInventor(ビーインベンター)のNao SeoChon氏に話を伺った。

【ヤマサキ × CHAOSRU】「誰も知らない技術」を、誰もが体験できる価値へ——創業151年の工業炉建設会社とVRスタートアップが挑む、採用×認知の壁の壊し方

明治8年創業の株式会社ヤマサキは、製鉄に欠かせない築炉の技術を持ちながら、業界・企業の認知度の壁が採用の課題となっていた。この課題の突破口を探るべく参加したのが、『ヤマサキ×オープンイノベーションプログラム2024』だ。プログラムを通じて、VR・XR技術を核とする株式会社CHAOSRUとの協業をスタート。2025年7月から始まったPoC(実証実験)では、高校生向け採用説明会へのVR体験の導入により、ブース来訪者数に明らかな変化が生まれている。アクセラレータープログラムを通じたスタートアップとの協業で何が動き、何が見えてきたのか。株式会社ヤマサキのプロジェクトリーダー 田中敏彦氏と、CHAOSRU代表取締役の内藤薫氏に話を伺った。